Impact on Obesity-Related Illnesses and Quality of Life Following Intragastric Balloon

Mui, Wilfred Lik-Man; Ng, Enders K.; Tsung, Bonnie Y.; Lam, Chuen Hing; Yung, Man Yee

doi:10.1007/s11695-008-9766-6

Cited by 72 publications

(60 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The EBL% of the LSG group in the first postoperative year was also significantly different from the IGB group (81.48 ± 18.8% and 41 ± 17.3%, respectively) (p<0.001). Overall our study shows that LSG is more efficient than IGB placement in treating morbidly obese patients, a result which is compatible with the literature [15,17].…”

Section: Discussionsupporting

confidence: 92%

See 1 more Smart Citation

Laparoscopic sleeve gastrectomy versus endoscopical intra-gastric balloon placement: early results of morbidly obese patients

Çaycı

Erdoğdu

2017

Archives of Clinical and Experimental Medicine

View full text Add to dashboard Cite

Atıf yazım şekli:How to cite:Cayci HM, Erdogdu U. Laparoscopic sleeve gastrectomy versus endoscopic intra-gastric balloon placement: Early results of morbidly obese patients. Arch Clin Exp Med. 2017;2(2):35-38.Abstract Aim: Endoscopic intra-gastric balloon (IGB) placement and laparoscopic sleeve gastrectomy (LSG) are widely used treatment modalities for weight loss in patients with morbid obesity. The aim of our study was to evaluate the results of these two methods in patients with morbid obesity. Methods: The data of 119 patients who were treated during the same time period for morbid obesity (Body Mass Index (BMI) ≥40 kg/m2) and completed a 12-month follow-up period were evaluated retrospectively. The study comprised twenty patients who underwent IGB placement and 99 LSG patients. Patients from these two groups were compared according to their demographic data; rate of comorbidity; weight and BMI changes both preoperatively and postoperatively at the 12 months; excess weight loss (EWL); and excess BMI loss (EBL ) nedeniyle aynı dönemde tedavi edilen ve 12 aylık takip dönemini tamamlayan 119 hastanın verileri retrospektif olarak değerlendirildi. Çalışmada İGB uygulanan 20 hasta ve LSG yapılan 99 hasta yer aldı. Hastaların demografik verileri, yandaş hastalık, preoperatif ve postoperatif 12. ayda kilo ve VKİ verileri, verilen fazla kilo ve yüzdeleri, verilen fazla VKİ ve yüzdeleri kaydedilip gruplar karşılaştırıldı. Bulgular: LSG ve İGB grupları arasında preoperatif kilo açısından istatiksel anlamlı farklılık olduğu görüldü (sırasıyla 124,3 ± 17 ve 145,5 ± 24,7; p<0,001). Postoperatif 12. ayda ölçülen kilo değerlendirildiğinde İGB grubunda ortalama 119,2 ±28,5 kg ve LSG grubunda 78,9 ± 12,9 kg saptandı (p<0,001). İGB grubundaki hastaların 12.ay sonunda ortalama 26,3 ±12,8 kg kilo verdiği, LSG grubundaki hastalarında 45,35 ±12,2 kg kilo verdiği görüldü (p<0,001). Postoperatif 12. ayda saptanan verilen fazla kilo yüzdesi İGB grubunda 33,42 ±9,2%, LSG grubunda 67,68 ±14,9% saptandı (p‹0,001). Postoperatif 12.ayda saptanan verilen fazla VKİ yüzdesi açısından İGB grubunda 41 ±17,3%, LSG grubunda 81,48 ±18,8% saptandı (p<0,001). Sonuç: Morbid obes hastalarda endoskopik İGB uygulaması cerrahiye uygun olmayan veya cerrahi tedaviyi tercih etmeyen hastalarda etkin ve güvenli bir tedavi seçeneği olarak tercih edilebilir. Anahtar kelimeler: Morbid obezite, laparoskopik sleeve gastrektomi, intragastik balon

show abstract

Section: Discussionsupporting

confidence: 92%

“…IGB placement is considered less efficient than definitive bariatric surgical interventions in terms of weight loss; but more effective than diet, exercise and lifestyle changes [15]. Moreover, initial BMI and the patient's motivation and compliance with the diet program significantly affect weight loss after IGB placement.…”

Section: Discussionmentioning

confidence: 99%

Laparoscopic sleeve gastrectomy versus endoscopical intra-gastric balloon placement: early results of morbidly obese patients

Çaycı

Erdoğdu

2017

Archives of Clinical and Experimental Medicine

View full text Add to dashboard Cite

show abstract

“…Most of those in the IGBG experienced GIrelated AEs. These were mainly reported during the initial adaptation phase (days [1][2][3][4][5][6][7][8][9][10][11][12][13][14] and mostly resolved during the second week post-insertion ( Figure 4). Consistent with this, when an analysis was conducted of the impact of the three most common symptoms (nausea, vomiting, and abdominal pain) on daily functioning (defined as: days off work or study), the mean (SD) number of days impacted during week 1 was: 3.7 (0.9), reducing to 0.6 (1.4) days during week 2.…”

Section: Safetymentioning

confidence: 99%

An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study

Fuller

Pearson

Lau

et al. 2013

Obesity

View full text Add to dashboard Cite

Objective: There are limited controlled data for intragastric balloons (IGB) in obesity treatment. This randomized, controlled study evaluated the efficacy and safety of an IGB in obese individuals with metabolic syndrome (MS). Design and Methods: Sixty-six adults (BMI: 30-40 kg/m 2 ) were randomized to IGB for 6 months, with a 12 month behavioral modification (IGB Group; ''IGBG''), or 12 month behavioral modification alone (Control Group; ''CG''). The primary outcome was percentage change in body weight. Results: Thirty-one subjects (female: 68%; mean age: 43; mean BMI: 36.0) were randomized to IGBG and 35 (66%; 48; 36.7) to CG. At 6 months, there was a significantly greater weight loss in the IGBG: À14.2 vs. À4.8; P < 0.0001. This was associated with a significantly greater reduction in waist circumference, and an improvement in quality of life, with a trend for a larger %MS remission (50% vs. 30%; n.s.). At month 12, the differences in weight loss were enduring: À9.2 vs. À5.2; P ¼ 0.007. Gastrointestinal-related adverse events were common in the IGBG, resolving predominantly within two weeks. The IGB was removed prematurely in three subjects (one for refractory gastrointestinal symptoms). Conclusions: Statistically significant and clinically relevant improvements in weight loss and health outcomes were observed with the IGBG at 6 months versus behavioral modification alone. The differential weight loss was still evident 6 months after IGB removal.

show abstract

“…One particular study followed 130 obese after gastric balloon therapy, and found their weight decreased by 13kg after six months of gastric balloon therapy [7]. Another study of 119 obese patients found the patients lost 12kg of body weight on average [8]. Furthermore, European trials found patients lose 25-40% of their excess weight after six months [9].…”

Section: How Effective Are Gastric Balloons For Weight Loss?mentioning

confidence: 99%

The Effect of Gastric Balloons on Weight Loss

Alenazi¹

2016

AOWMC

View full text Add to dashboard Cite

Submit Manuscript | http://medcraveonline.com volume and therefore increases satiety [5]. This literature review will examine the effect of gastric balloons on weight loss. First the review will examine the effectiveness of gastric balloons for weight loss, and then the review will consider hoe permanent the weight loss is. Then the review will examine who is suitable for gastric balloons, and finally his review will consider the method by which gastric balloons cause weight loss.

show abstract

Impact on Obesity-Related Illnesses and Quality of Life Following Intragastric Balloon

Abstract: IGB produces meaningful weight loss and significantly improves obesity-related illnesses and quality of life.

Cited by 72 publications

References 22 publications

Laparoscopic sleeve gastrectomy versus endoscopical intra-gastric balloon placement: early results of morbidly obese patients

Laparoscopic sleeve gastrectomy versus endoscopical intra-gastric balloon placement: early results of morbidly obese patients

An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study

The Effect of Gastric Balloons on Weight Loss

Contact Info

Product

Resources

About